Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Bull Market and Beyond: 2 Stocks Just Waiting to Soar


Any stock can have an impressive run, especially when broader equities are experiencing a bull market. Significantly fewer stocks can perform well through good and not-so-good times and deliver excellent returns over long periods. These are precisely the sort of corporations that long-term investors should seek out although they can be hard to find.

It's worth the effort, though, and to make the job a bit easier, here are two potential candidates: Vertex Pharmaceuticals (NASDAQ: VRTX) and Axsome Therapeutics (NASDAQ: AXSM). Both biotechs have important short-term catalysts and excellent long-term prospects that should help boost their stock prices.

Vertex Pharmaceuticals might look like an odd pick for a list of stocks ready to soar. The biotech has generally performed as well, if not much better, than the broader market. Thanks to its monopoly in the market for medicines that target the underlying causes of cystic fibrosis (CF), the drugmaker's financial results are solid and consistent.

Continue reading


Source Fool.com

Vertex Pharmaceuticals Inc. Aktie

422,25 €
-0,05 %
Nur eine minimale Kursabweichung bei Vertex Pharmaceuticals Inc. seit gestern, um -0,05 %.
Vertex Pharmaceuticals Inc. wird von der Community favorisiert: Deutlich mehr Buy- als Sell-Einschätzungen.
Für Vertex Pharmaceuticals Inc. ergibt sich ein leicht positives Potenzial, angesichts eines Kursziels von 440 € im Vergleich zu 422.25 €.
Like: 0
Teilen

Kommentare